Free Trial
ASX:EX1

Exopharm (EX1) Stock Price, News & Analysis

About Exopharm Stock (ASX:EX1)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$1.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EX1 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exopharm and its competitors with MarketBeat's FREE daily newsletter.

EX1 Stock News Headlines

Tryptamine Therapeutics Ltd (TYP)
Banks aren’t ready for this altcoin—are you?
The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.
EX1 - Weather warnings issued
Exopharm Limited (EX1.XA)
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:EX1
CIK
N/A
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$4.32 million
Net Margins
-1,756.70%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$1.18 million
Price / Cash Flow
3.39
Book Value
A$0.02 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$1.93 million
Optionable
Not Optionable
Beta
1.26
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (ASX:EX1) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners